Oxytetracycline biosynthesis.
Oxytetracycline (OTC) is a broad-spectrum antibiotic that acts by inhibiting protein synthesis in bacteria. It is an important member of the bacterial aromatic polyketide family, which is a structurally diverse class of natural products. OTC is synthesized by a type II polyketide synthase that generates the poly-beta-ketone backbone through successive decarboxylative condensation of malonyl-CoA extender units, followed by modifications by cyclases, oxygenases, transferases, and additional tailoring enzymes. Genetic and biochemical studies have illuminated most of the steps involved in the biosynthesis of OTC, which is detailed here as a representative case study in type II polyketide biosynthesis.
Pickens
Lauren B
LB
Department of Chemical and Biomolecular Engineering, University of California, Los Angeles, California 90095, USA.
Tang
Yi
Y
D000900:Anti-Bacterial Agents / Q000096:biosynthesis* / Q000737:chemistry; D003500:Cyclization; D024881:Drug Resistance, Bacterial / Q000235:genetics; D018942:Macrolides / Q000378:metabolism; D010118:Oxytetracycline / Q000096:biosynthesis* / Q000737:chemistry; D013754:Tetracyclines / Q000378:metabolism
D000900:Anti-Bacterial Agents; D018942:Macrolides; D013754:Tetracyclines; C016229:4-epianhydrotetracycline; D010118:Oxytetracycline